about
Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsElectrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review articleMicroRNAs in skin and wound healing.Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activitye-Health Tools for Targeting and Improving Melanoma Screening: A Review.A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme.Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care.Molecular changes induced by the curcumin analogue D6 in human melanoma cells.Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patientsMolecular targets in melanoma: time for 'ethnic personalization'Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years.Targeting the RAS pathway in melanoma.A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma.BRAF and MEK gene rearrangements in melanoma: implications for targeted therapy.Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Assessment of attitudes towards sun-protective behaviour in Australians: A cross-sectional study.Selenium-containing histone deacetylase inhibitors for melanoma management.c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.Near infrared and skin impedance spectroscopy - a possible support in the diagnostic process of skin tumours in primary health care.Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and AttachmentVariables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma.Andrographolide inhibits proliferation and induces cell cycle arrest and apoptosis in human melanoma cells.Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanomaAssociation between melanoma thickness, clinical skin examination and socioeconomic status: Results of a large population-based study
P2860
Q28485237-26E9AF07-A84D-4F73-BA8C-9EC5D3A6766FQ34020065-17183A6D-83EB-4D74-83F9-1755EAC1E291Q34183543-8307F4DB-E2D7-441A-81AC-42A7EA7C6F6AQ35033659-09E25B58-E0E9-45F8-A22E-3AA3FBF9F0AEQ35234721-78206876-C59E-4E2E-8E9A-18BE9C937777Q36490593-42A82E39-EDDB-462A-AD95-2E88D5EE03BEQ36557193-A65A246A-83EE-4F29-8E2F-7D867516A4C2Q36691476-79C061C9-F896-426D-8DFC-C3C864B0520CQ36836630-FB3041AA-2698-488F-B179-75EEA9D9E1CFQ36889688-AF28F593-CAB9-4588-8C4A-AB3B053BC17FQ36927065-1A0D36CC-98BD-4749-AB14-D6A0DBD0B18EQ37124250-387D9980-F969-4C37-B63B-7EF2A8909AA1Q37137004-4D46FB55-6CF4-4CA3-8E49-3D369C4BDB74Q37459121-303C2AC7-660B-4574-AF6D-47B88C9B3945Q38124821-691E7D13-D052-45E7-8291-CE79D254ED4AQ38176858-DA5206DB-A1B8-4F8E-9E30-FA86B18C0EF3Q38185688-51802260-0265-4D17-8191-406699AD450FQ39023541-06C3D469-27A1-4CF4-A6F6-169323B76A4AQ39336516-3AA474D7-63C0-4E81-99B6-8D7574E3F1A6Q39719008-1D0A3F08-78A2-46EF-9FEC-2F98B172E57EQ41217075-04DE700C-2E63-4238-8FB4-63AA11CE8C93Q41667860-50601618-C032-4EC5-B055-2BB159754687Q47103823-CCA85E48-FA1F-4A84-ACDE-956E788C8500Q47160476-3F11356C-4818-4B6F-8B8D-E21122AC296AQ52649711-25B4ADAD-B2C0-4A7E-8953-2110D5C472EEQ58796907-DFC3512A-EA89-447C-A76A-71F2556BCED9Q59235097-A774C1CF-FEDC-40A3-B53F-DA35F92E65E1
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Melanoma epidemiology and public health.
@ast
Melanoma epidemiology and public health.
@en
Melanoma epidemiology and public health.
@nl
type
label
Melanoma epidemiology and public health.
@ast
Melanoma epidemiology and public health.
@en
Melanoma epidemiology and public health.
@nl
prefLabel
Melanoma epidemiology and public health.
@ast
Melanoma epidemiology and public health.
@en
Melanoma epidemiology and public health.
@nl
P2860
P1433
P1476
Melanoma epidemiology and public health
@en
P2093
Esther Erdei
Jennifer Hay
P2860
P304
205-14, viii
P356
10.1016/J.DET.2008.12.002
P577
2009-04-01T00:00:00Z